New York, January 17, 2019— Creative Biolabs, a leading custom service provider in the field of vaccine development, preclinical assessment and GMP manufacturing, now releases a series of vaccine assessment services to provide a solution that aligns with unique needs of global clients.
Vaccines are administered to healthy humans, often in the first year of life. Vaccine test in vivo is a practicable and highly efficient method to assess the potency and safety of human vaccines and enlighten the long and grueling path of vaccine development.
In Creative Biolabs, vaccines assessment services in a variety of animal model are provided for studying disease pathogenesis, host-pathogen interactions and protection mechanisms after vaccination, infections or disease treatment. Natural disease models helps to understand the immunopathogenesis, analyze the virulence factors and their roles in invasion, penetration, and toxicity as well as host’s immune responses to pathogens, while surrogate models provide a useful tool for studying specific aspects of disease pathogenesis and host immune response.
Vaccine development also requires pre-clinical toxicology studies, following good laboratory practice (GLP), before first in human (phase I) use. Creative Biolabs offers a series of GLP toxicology and safety testing to provide safety evidence for vaccine clinical trials and registration, increasing confidence in the rigor with which any potential risks or side-effects are investigated and managed. Vaccine toxicology testing for new vaccine pre-clinical assessment include single dose, repeat doses, immune response, safety pharmacology, reproductive toxicology, genotoxicity, toxicity due to the active ingredients or excipients and reactions with impurities.
Over past ten years, Creative Biolabs has gained a much high reputation through high-quality services and products with rapid experimental timelines and competitive prices, helping clients through the assessment stages of development with the excellent preclinical GLP toxicology and safety testing and vaccine in vivo assays. In addition, non-animal assessment (Vaccine Assessment In Vitro Assays) are available in Creative Biolabs to meet different customer’s demands. Please visit https://www.creative-biolabs.com/vaccine for more information on vaccine development services.
Author Bio
Creative Biolabs, headquartered in New York, is a leading custom service provider in the field of vaccine development, preclinical assessment and GMP manufacturing. The technical and regulatory experts can provide vaccine developers with a full range of products and vaccine related services. Traditional and the most updated genetic engineering technologies are combined to efficiently produce highly immunogenic and safe vaccines to address emergency unmet medical needs. The service portfolio includes a full range of vaccine design for client’s specific requirements that covers vaccine target validation, vaccines targeting bacterial, viral, fungal, parasites, cancer markers and more. Formulation optimization services are also available for maximum potency, including improving delivery systems, a great variety of adjuvant products and services like PRR Ligands scanning and adjuvants synthesis.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-619-7922
Address:45-1 Ramsey Road
City: Shirley
State: New York
Country: United States
Website: https://www.creative-biolabs.com/vaccine
Source: www.abnewswire.com
